Better Health for All

Alerus Financial Corporation's core business is financial services, which have no significant direct positive or negative health impact. The company's products and services do not have direct safety implications, carry health risks requiring disclosure, or involve health-related pricing. There is no evidence of revenue from products with negative health outcomes, significant health externalities, or engagement in preventative health or treatment activities. The company does not collect or manage health-related data, conduct clinical trials, or hold healthcare-related patents. There is no information regarding its involvement in global health crisis response, mental health initiatives, or nutrition and food safety. While Alerus made a $1 million commitment to a new hospital,

the articles do not provide the necessary context (e.g., total R&D or capital allocation) to score this as a 'share' of investment, nor do they provide specific data on vulnerable reach, health equity programs, or healthcare workforce support.

Fair Money & Economic Opportunity

The provided articles, which are summaries of Alerus.com CRA Public Files, explicitly state that they do not contain quantitative data, regulatory actions, certifications, comparisons, contradictions, or data gaps suitable for extracting the requested metrics.

Therefore, no specific evidence could be found to assess Alerus Financial Corporation against any of the KPIs for Fair Money & Economic Opportunity.

Fair Trade & Ethical Sourcing

Alerus Financial Corporation is a diversified financial services company.

The provided articles do not contain specific evidence related to its procurement of physical commodities or its supply chain practices concerning fair trade, ethical sourcing, or labor conditions. Therefore, several KPIs are scored as N/A because the organization does not procure physical commodities, has no supplier base requiring welfare or sourcing audits, or no supply chain tiers to map. There is no evidence regarding forced or child labor incidents, nor ethical clauses in supplier contracts.

Kind to Animals

Alerus Financial Corporation is a diversified financial services company offering banking, mortgage, retirement, and wealth management services. The provided articles contain no specific data points regarding animal welfare, animal testing, animal-derived products, or related ethical considerations for the company.

Given the nature of its business, the KPIs related to animal welfare are not applicable to its core operations, as it does not produce physical products, conduct animal testing, or engage in animal husbandry or agriculture.

No War, No Weapons

Alerus Financial Corporation is stated to have no military contracting and no controversial weapons in its product and activity categories.

This indicates that the company does not engage in defense or arms-related activities in its core business and has no exposure to any weapons.

Safe & Smart Tech

Alerus has a formal, documented information security program, reviewed annually by the Board of Directors.

All employees receive mandatory annual cybersecurity awareness training, and ongoing training on identity theft and fraud, indicating a high completion rate. All data is encrypted in transit and at rest, which is a standard practice. Multi-factor authentication is used for remote access, but the article does not specify the percentage of services covered, which aligns with the -50 tier. The company performs daily and weekly vulnerability scans and deploys patches weekly. While the exact patching timeframe for critical vulnerabilities is not specified, 'patches weekly' suggests a timeframe that falls within the -60 tier. Alerus employs a secure system development lifecycle (SDLC) with change management and cross-functional reviews, which is a standard approach to privacy by design. The company conducts annual IT risk assessments, considering audit results and penetration testing, and engages third-party vendors for annual audits, but the scope and frequency of security testing across all systems are not detailed, placing it at -70. Alerus states compliance with the Gramm-Leach-Bliley Act (GLBA) and the Federal Financial Institutions Examination Council's IT Examination Handbook, but no specific details on compliance program strength or regulatory actions are provided. There is no evidence regarding data breaches, AI ethics, cybersecurity investment, privacy certifications, unauthorized data use, user data control, bug bounty programs, algorithmic transparency, or algorithmic harm remediation.